Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease

被引：33

作者：

Patton S.M. ^{[1
]}

Cho Y.W. ^{[2
]}

Clardy T.W. ^{[1
]}

Allen R.P. ^{[3
]}

Earley C.J. ^{[3
]}

Connor J.R. ^{[1
]}

机构：

[1] Department of Neurosurgery, Penn State University, Milton S. Hershey Medical Center, Hershey, PA 17033

[2] DongSan Medical Center, Keimyung University, Taegu

[3] Bayview Medical Center, Johns Hopkins School of Medicine, Baltimore, MD

来源：

Fluids and Barriers of the CNS | / 10卷 / 1期

关键词：

Hypoxia inducible factor; Nitric oxide; Pain; Restless legs syndrome/Willis-Ekbom disease; Sleep disorders;

D O I：

10.1186/2045-8118-10-20

中图分类号：

学科分类号：

摘要：

Background: Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED) is a sensorimotor disorder that causes patients to experience overwhelming and distressing sensations in the legs compelling the patient to move their legs to provide relief. The purpose of this study was to determine if biomarkers in the cerebrospinal fluid can distinguish RLS/WED patients from neurological controls.Methods: We obtained CSF samples by lumbar puncture from 5 early-onset RLS/WED patients and 5 controls. We performed 2-dimensional difference in-gel electrophoresis (2D-DIGE). Proteins that were significantly altered were identified by Student's t-test. Protein spots that were differentially expressed (p ≤ 0.05, Av. Ratio ≥ 2.0) between RLS/WED and control CSF samples were identified using MALDI-TOF-MS. Statistical analyses of the validation immunoblot assays were performed using Student's t-test.Results: In this discovery study we identified 6 candidate CSF protein markers for early-onset RLS/WED. Four proteins (Cystatin C, Lipocalin-type Prostaglandin D2 Synthase, Vitamin D binding Protein, and β-Hemoglobin) were increased and 2 proteins (Apolipoprotein A1 and α-1-acid Glycoprotein) were decreased in RLS/WED patients.Conclusions: Our results reveal a protein profile in the RLS/WED CSF that is consistent with clinical findings of disruptive sleep, cardiovascular dysfunction and painful symptoms. Moreover, protein profiles are consistent with neuropathological findings of activation of hypoxia inducible factor (HIF) pathways and alterations in dopaminergic systems. These data indicate the CSF of RLS/WED patients may provide information relevant to biological basis for RLS/WED, treatment strategies and potential new treatment targets. © 2013 Patton et al.; licensee BioMed Central Ltd.

引用

共 47 条

[1]

Allen R.P., Walters A.S., Montplaisir J., Hening W., Myers A., Bell T.J., Ferini-Strambi L., Restless legs syndrome prevalence and impact: REST general population study, Arch Intern Med, 165, pp. 1286-1292, (2005)

[2]

Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisi J., Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health, Sleep Med, 4, pp. 101-119, (2003)

[3]

Earley C.J., Silber M.H., Restless legs syndrome: understanding its consequences and the need for better treatment, Sleep Med, 11, pp. 807-815, (2010)

[4]

Ulfberg J., Nystrom B., Carter N., Edling C., Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms, Mov Disord, 16, pp. 1159-1163, (2001)

[5]

Winkelman J.W., Finn L., Young T., Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort, Sleep Med, 7, pp. 545-552, (2006)

[6]

Winkelman J.W., Shahar E., Sharief I., Gottlieb D.J., Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study, Neurology, 70, pp. 35-42, (2008)

[7]

Ohayon M.M., Roth T., Prevalence of restless legs syndrome and periodic limb movement disorder in the general population, J Psychosom Res, 53, pp. 547-554, (2002)

[8]

Allen R.P., Earley C.J., The role of iron in restless legs syndrome, Mov Disord, 22, SUPPL. 18, (2007)

[9]

Allen R.P., Barker P.B., Wehrl F., Song H.K., Earley C.J., MRI measurement of brain iron in patients with restless legs syndrome, Neurology, 56, pp. 263-265, (2001)

[10]

Godau J., Klose U., Di Santo A., Schweitzer K., Berg D., Multiregional brain iron deficiency in restless legs syndrome, Mov Disord, 23, pp. 1184-1187, (2008)

← 1 2 3 4 5 →